Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

One-pot synthesis of compact DNA silica particles for gene delivery and extraordinary DNA preservation

  • Ramos-Valle, A.
  • Marín-Caba, L.
  • García Hevia, Lorena
  • Correa Duarte, Miguel Ángel
  • Fanarraga, M.L.
Repairing genetic defects using exogenous DNA is a major challenge the science is currently facing. This requires the design of vectors that can effectively encapsulate, protect and target nucleic acids to specific cells safely and precisely. Here we have designed silica-based physiologically responsive particles to encapsulate, store, and transfer DNA. Unlike existing vectors (e.g., viral or lipidic particles), these DNA@SiO2 systems are very stable at room temperature. We also demonstrate how they protect the encapsulated DNA from exposure to different biological and physicochemical stresses, including DNase, denaturation temperatures (>100 C), or reactive oxygen species (ROS). Remarkably, upon cellular uptake, these vectors dissolve safely unpacking the DNA and transfecting the cells. The versatility of the design is such that it can encapsulate genes without gene/size restrictions, in single or multiple layers of silica, so different genes can be expressed sequentially. This allows the timecontrolled transcription of several genes, mimicking viral gene expression cascades, or even “fine-tuning” gene expression in transfected cells on demand. In addition, the method is easily scalable, reproducible, and inexpensive, enabling large-scale production and batch-quality testing, all of which are important for the personalized therapeutics industry. The high stability of these DNA vectors allows for easy and low-cost transport from the point of production to virtually any destination, making them unique as gene delivery tools., Interreg Atlantic Area, European Regional Development Fund-ERDF | Ref. NANOCULTURE (ERDF: 1.102.531), Instituto de Salud Carlos III | Ref. PI22/00030, Instituto de Salud Carlos III | Ref. PI19/00349, Agencia Estatal de Investigación | Ref. PID2020‐113704RB‐I00, Xunta de Galicia | Ref. IN607A 2018/5, Xunta de Galicia | Ref. ED431G 2019/06, Agencia Estatal de Investigación | Ref. TED2021-129248 B–I00, Unión Europea-FEDER (Interreg V-A—España-Portugal) | Ref. 0624_2IQBIONEURO_6_E, Unión Europea-FEDER (Interreg V-A—España-Portugal) | Ref. 0712_ACUINANO_1_E, Instituto de Investigación Sanitaria IDIVAL | Ref. INNVAL21/19, Instituto de Investigación Sanitaria IDIVAL | Ref. IDI 20/22, Instituto de Investigación Sanitaria IDIVAL | Ref. IDI-020-022
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

A custom-made functionalization method to control the biological identity of nanomaterials

  • Padín González, Esperanza
  • Navarro Palomares, Elena
  • Valdivia B., Lourdes
  • Iturrioz Rodríguez, Nerea
  • Correa Duarte, Miguel Ángel
  • Valiente, Rafael
  • Fanarraga, Mónica L.
Here we propose a one-step strategy to endow nanomaterials with a custom-designed bio-identity. This study designs a universal ‘nanomaterial binding domain’ that can be genetically attached to any protein ensuring precise and spontaneous protein orientation. We demonstrate how, despite the simplicity of the method, the bioconjugation achieved: (i) is highly efficient, even in the presence of competing proteins, (ii) is stable at extreme physiological conditions (pH ranges 5.2-9.0; NaCl concentrations 0-1 M); (iii) prevents unwanted protein biofouling days after incubation in biologically-relevant conditions; and finally, (iv) avoids nanoparticle interaction with promiscuous unspecific receptors. In summary, this protein biocoating technique, applicable to a wide array of nano-designs, integrates material science and molecular biology procedures to create hybrid nanodevices with well-defined surfaces and predictable biological behaviors, opening a chapter in precision nanodiagnostics, nanosensing or nanotherapeutic applications., Agencia Estatal de Investigación | Ref. MAT2016-81955-REDT, Instituto de Salud Carlos III | Ref. PI19/00349, Instituto de Salud Carlos III | Ref. DTS19/00033, Ministerio de Economía y Competitividad | Ref. CTM2014-58481-R, Agencia Estatal de Investigación | Ref. CTM2017-84050R, Agencia Estatal de Investigación | Ref. PGC 2018-101464-B-I00, Ministerio de Educación, Cultura y Deporte | Ref. FPU15/06881, Xunta de Galicia, Instituto de investigación sanitaria Valdecilla (Cantabria) | Ref. PREVAL16/02, Instituto de investigación sanitaria Valdecilla (Cantabria) | Ref. NNVAL17/11
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Graphene-encapsulated magnetic nanoparticles for safe and steady delivery of ferulic acid in diabetic mice

  • Zhong, Baihua
  • Mateu-Roldán, Adán
  • Fanarraga, Mónica L.
  • Han, Wei
  • Muñoz-Guerra, Débora
  • González, Jesús
  • Tao Weng, Lu
  • Ibarra, M. Ricardo
  • Marquina, Clara
  • Lun Yeung, King
Iron nanoparticles encapsulated within graphene shells (Fe@C) were examined for cellular internalization, subcellular behavior, biocompatibility, and influence on cell viability and proliferation. Studies on human lung (adenocarcinoma human alveolar basal epithelial) and skin (epidermoid carcinoma) cells indicate Fe@C is less toxic and more biocompatible than the magnetite nanoparticles coated by an amorphous carbon (Fe3O4@C). Fe3O4@C exhibited more signs of degradation than Fe@C when exposed to murine macrophages (mouse monocyte-macrophages J774). Unlike Fe3O4@C, Fe@C has a high drug loading capacity (0.18 g/g) for ferulic acid, an active pharmaceutical ingredient found in the traditional Chinese herb Angelica sinensis and releases the drug at a constant dosing rate of 8.75 mg/g/day over 30 days. Ferulic acid released by Fe@C injected subcutaneously in diabetic BALB/c mice is effective in lowering the blood glucose level.